There are two categories of aging process with intrinsic and extrinsic aging. The former is represented by internal factors as accompanied by genetic events, and the latter is related to external factors such as stress, radiation, pollution, and smoking. 1 Aging skin has features in changes in skin thickness, epidermal and dermal layer which appear as wrinkles, and structural abnormalities including degeneration of dermal elastic fibers. 2 Clinically, the skin becomes coarse, then thins, and becomes lax, showing sallowness, wrinkles, irregular hyperpigmentation, lentigines, and telangiectasias. 3
and generation of collagen. 5 Wrinkle researches have been developed with animal and in vitro models. 6 Keratinocytes release inflammatory cytokines including interleukin (IL)-1, IL-6, IL-8, IL-10, and tumor necrosis factor (TNF)-α upon exposure to UV. 7 UVB-induced cell damage leads to activation of reactive oxygen species (ROS)sensitive signaling pathways, such as the mitogen-activated protein kinase (MAPK) pathway. 8 This pathway is an important mediator of inflammatory cytokine induction in response to UVB irradiation. 9 Various cosmetics can inhibit skin wrinkles, distinct from drugs, which are used for a set period for the treatment of medical conditions. 10 It is important to secure the safety of cosmetics because they are routinely used for a long time. 11 The safety of skin applications is determined individually based on the ingredients used. 12 It is performed on the subjects who have normal skin, and the appearance of erythema, edema, swelling, and papules is evaluated by experts to determine product safety. 13 The rhizomes of Anemarrhena asphodeloides Bunge (Liliaceae) have been used in traditional medicine as an antidiabetic, an antipyretic, and an antidepressant in China, Japan, and Korea. It is also used to treat febrile disease in clinical practice in China. 14, 15 Various chemical constituents are reported to be present in A asphodeloides, among which timosaponin A-III (TA-III) has various pharmacological efficacy and is used as an antidiabetic, antipyretic, and antidepressive material in traditional medicine. [15] [16] [17] [18] In previous research, TA-III inhibits metastasis. 19 However, there is no study to protect photoaging caused by UVB.
In order to identify potential antiwrinkle agent, various compounds from A asphodeloides were evaluated in HaCaT cells. In skin clinical trials, the safety of TA-III and the effect of inhibiting skin wrinkles were examined and confirmed for use as cosmetics for skin wrinkle prevention.
| MATERIAL S AND ME THODS

| Isolation process
Timosaponin A-III (TA-III; Figure 1 ) was isolated as previously described. 20 
| UVB irradiation and cell viability assay
An immortalized nontumorigenic human keratinocyte cell line (HaCaT) (1 × 10 4 ) was seeded into 96-well culture plates and exposed to 20 mJ/cm 2 of UVB in the presence or absence of TA-III for 24 hr Immediately after UVB irradiation, cell viability was assessed by incubation with 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) for 1 hr and measuring its reduction to formazan, according to the manufacturer's instructions; samples were assayed at 490 nm using a microplate spectrophotometer (Molecular Devices).
| Analysis of MMP-1 secretions by ELISA
After UVB irradiation, MMP-1 levels in the culture media of HaCaT cells (5 × 10 4 ) were determined using human total MMP-1 ELISA 
| Quantitative real-time polymerase chain reaction (qRT-PCR) assays
Total RNA was extracted from each sample using TRIzol (Invitrogen). 
| Limitations and assessment criteria
While the patches were in place, the subjects were instructed not to let the testing area (back) come into contact with water.
Observations were made 30 min and 24 hr after patch removal, and skin reactions were assessed according to the criteria of the Frosch & Kligman method 21 and the guidelines of the Personal Care Product Council (PCPC; Table 2 ). 22
| Calculation of results
The average reactivity at 48 and 72 hr was calculated using the equation below, and the average reactivity to each individual solution was determined according to the Frosch & Kligman criteria (Table 3) . There are excessively numerous deep wrinkles on the skin *Wrinkles were assessed in 0.5-unit increments.
| Antiwrinkle clinical trials
| Patients and methods
The study was conducted in accordance with the intent and purpose of good clinical practice regulations as described in Korean Good 
| Visual assessment of skin wrinkles
Wrinkles around the eyes were independently assessed under specific lighting conditions. At each assessment, wrinkles were graded into 10 stratified grades in 0.5-point increments; the mean of the two values chosen by the two evaluators was used in the statistical analysis (Table 4 ). 
| Evaluation of skin wrinkle parameters using skin replicas
| Subject questionnaire
| Statistical analysis
All data were analyzed for statistical significance using the SPSS ® Package Program (IBM). For the visual assessment, the evaluators were considered reliable when the intraclass correlation coefficient was >0.8, and the mean value was analyzed. The normality of the distribution was tested using kurtosis and skewness, and prehomogeneity was verified using a paired t test. A repeated-measures analysis of variance (ANOVA) was used to determine interdependence (or reciprocal action) between repeated measurements, as well as to compare groups.
Statistical analysis was done in terms of comparison between both groups (test vs control group).
The efficacy questionnaire was evaluated using the Mann-Whitney U test to compare the two groups in terms of nonparametric mean values; the product usability questionnaire was evaluated using the chi-squared test. Statistical significance was defined as a P-value < 0.05.
| RE SULTS
| Photoprotective effects of TA-III on HaCaT cells
UVB irradiation reduced cell viability to 49.6% as compared with the control level. However, incubating the cells with 0.1 µmol/L of TA-III prior to irradiation, cell viability was maintained at 100.4% of the control level (Figure 2 ).
| MMP-1 inhibition by TA-III
To find out active compound in A asphodeloides, extracts and various compounds (timosaponin A-III, timosaponin B, timosaponin B-II, anemarsaponin B, anemarsaponin E, and timosaponin C) from A asphodeloides were evaluated in terms of skin wrinkle reduction as measured by MMP-1 level in UVB-treated cells. MMP-1 levels were increased by UVB irradiation (Figure 3 ). Among them, TA-III showed strong activity on MMP-1 inhibition. Also, TA-III was isolated as major compound in A asphodeloides.
| Effects of TA-III on TIMP and inflammatory cytokines
The mRNA levels of TIMP were measured by RT-PCR after UVB irradiation of HaCaT cells. The level of TIMP was decreased after UVB irradiation, as compared to the control group ( Figure 4A ). In results of mRNA expression, TA-III increased TIMP mRNA levels as compared with the UVB-irradiated cells.
The expression of pro-inflammatory cytokine mRNA transcripts was investigated in TA-III-treated cells. According to the result in 
| Subjects included in the skin safety test
A total of 30 individuals participated in safety test. The mean age of the subjects was 42.1 ± 5.2 years, with the oldest being 50 years old and the youngest being 27 years old. The skin characteristics of the study subjects were examined through surveys, and the results are presented in Table 6 . During the study period, no skin reactions to the test solution (TA-III) were observed (Table 7) .
| Skin characteristics of subjects for antiwrinkle test
A total of 23 women aged 43-55 years were included in this test.
Two subjects dropped out (No. 4 and No. 12) for personal reasons;
the clinical trial was conducted with 21 subjects. After finishing the clinical evaluation, the questionnaire was used to determine the characteristics of the subjects participating in clinical trial as shown in Table 8 .
F I G U R E 5 Changes in visual assessment following 12 consecutive weeks of application of the product (TA-III) and control groups (mean ± SEM, **P < 0.01, ***P < 0.001 vs before treatment, † † P < 0.01 vs control group)
| Visual assessment
In comparison within groups, wrinkles around the eyes were significantly ameliorated after both 8 and 12 weeks in the test group (P < 0.01, Table 9 ). In the control group, wrinkle reduction was shown after 12 weeks (P < 0.01, Table 9 ). In comparison between groups, the test group (TA-III) showed significant wrinkle reduction after 12 weeks (P < 0.01, Figure 5 ). Comparisons within groups (4, 8, and 12 
weeks)
In the test group (TA-III), Rt, Rm, and Ra were significantly reduced after 4, 8, and 12 weeks of product use, while Rz was significantly reduced after 8 and 12 weeks of product use and
Rp was significantly reduced after 12 weeks of product use (P < 0.01). In the control group, Rt, Rm, and Rz were significantly reduced after 8 and 12 weeks of product use (P < 0.05; Table 10 , Figure 6A -E).
F I G U R E 6 Evaluation of skin wrinkle parameters using replica. A, Changes in skin roughness (Rt) following 12 consecutive weeks of application of the test (TA-III) and control groups. B, Changes in maximum roughness (Rm) following 12 consecutive weeks of application of the test (TA-III) and control groups. C, Changes in average roughness (Rz) following 12 consecutive weeks of application of the test (TA-III) and control groups. D, Changes in smoothness depth (Rp) following 12 consecutive weeks of application of the test (TA-III) and control groups. E, Changes in arithmetic average roughness (Ra) following 12 consecutive weeks of application of the test (TA-III) and control groups (mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001 vs before treatment, † P < 0.05, † † P < 0.01, † † † P < 0.001 vs control group)
| Comparison between groups (control group and test group)
In the test group (TA-III), Rt was significantly improved in the test group compared with the control group after 4, 8, and 12 weeks of product use; Rm, Rz, and Ra were significantly improved in the test group compared with the control group after 12 weeks of product use (P < 0.05; Table 11 , Figure 6A -E).
| Subject questionnaire
| Product efficacy questionnaire
Among all participants, 76%-86% of subjects in both the test and control groups responded positively to the items "Increase of skin moisture" and "Improvement of skin softness" after 8 and 12 weeks.
Also, 48%-62% of subjects in both the test and control groups responded positively to the item "Improvement of skin glossiness,"
"Improvement of skin elasticity," and "Decrease of skin wrinkle" after 8 and 12 weeks; this did not constitute a significant difference (Table 12 and Figure 7 ).
| Product usability questionnaire
In both the test (TA-III) and control groups, 48%-62% and 43%-62% of subjects, respectively, responded positively to the items "color," "viscosity," "absorptivity," and "satisfaction," but there was no significant difference between the groups (Table 13 and Figure 8 ).
| D ISCUSS I ON
Skin aging may result from cumulative exposure to environmental factors related to wrinkle formation. 23 Aging over time is a natural process caused by internal physiological factors that affect the skin similarly to other organs, leading to formation of relatively slight wrinkle. 24 By contrast, photoaging is correlated with exposure to the UV radiation in sunlight, which strongly contributes to a premature aging phenotype. 25 Skin elasticity is reduced by the extracellular matrix degeneration with aging, and it is the most common feature of skin aging. 26 Wrinkles are formed by the breakdown of extracellular matrix such as collagen and elastin. 27 The complex mechanism such as collagen degradation and inhibition of new collagen production results in wrinkle formation in the dermis. 28 TA B L E 11 Statistical analysis of skin wrinkle parameter between the test and control groups (P-value) TA B L E 1 2 Results of positive answers in self-assessment for efficacy (n = 21)
Timosaponin A-III (TA-III) is present as one of the major chemical constituents in A asphodeloides rhizomes, and it is reported to have various biological effects. 29, 30 In this research, we confirmed the photoprotective activity of TA-III and compounds against UVB damage on skin cells.
MMPs and TIMPs are playing a role in the regulation of collagen metabolism. 31 MMPs produced by UVB exposure cause collagen degradation or inhibition of collagen synthesis, resulting in weak skin connective tissue. 32, 33 We have already eval- Keratinocyte induces the NF-κB pathway and inflammatory cytokines when exposed to UVB. These are associated with skin inflammatory responses. 34 the expression level of MMP-1 in fibroblasts. 35 The qRT-PCR analyses showed that TA-III attenuated the UVB-induced production of pro-inflammatory cytokine mRNAs in HaCaT cells, including IL-1β, IL-8, and TNF-α. This study demonstrated that exposure to UVB upregulated pro-inflammatory cytokines and MMPs. The expression of inflammatory cytokines was increased by UVB irradiation in HaCaT cells which decreased the cell viability, but this phenomenon was suppressed by TA-III.
In further study of clinical trials, the clinical safety of an agent containing 0.25% of TA-III for use on human skin was performed.
In comparison between groups, there was a significant difference in wrinkle parameters measured by replica at different time points.
Furthermore, replica analysis in comparison between the control and test groups, Rt was significantly improved in the test group compared with the control group after 4, 8, and 12 weeks of product use; Rm, Rz, and Ra showed significant difference in the test group compared with the control group after 12 weeks of product use (P < 0.05).
Safety and toxicity are important considerations for cosmetic products, as application of the product to the skin could lead to systemic exposure, resulting in adverse localized effects such as irritation, sensitization, or photoreactions. 11 Currently, a variety of naturally occurring agents that have antiaging effects are being used in skin care products. 36, 37 In general, the effectiveness of cosmetics is assessed by clinical trial experts and wrinkle assessment is considered a primary endpoint. 38, 39 According to skin safety results in this study, no dermatological problems were observed in subjects participating in clinical trial. In conclusion, TA-III attenuated UVB-induced skin damage and daily application of TA-III for 12 weeks significantly reduced signs of facial aging by limiting wrinkle formation.
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